Arcus Biosciences Cash from Financing (Quarterly) Analysis

Arcus Biosciences Inc (RCUS)

15.56 +0.82 (+5.60%) USD | NYSE | Apr 26, 16:00

15.56 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	3.00M
September 30, 2023	6.00M
June 30, 2023	23.00M
March 31, 2023	1.00M
December 31, 2022	11.00M
September 30, 2022	3.00M
June 30, 2022	4.00M
March 31, 2022	15.00M
December 31, 2021	11.33M
September 30, 2021	1.318M
June 30, 2021	2.231M
March 31, 2021	222.12M
December 31, 2020	2.002M
September 30, 2020	107.52M

Date	Value
June 30, 2020	328.87M
March 31, 2020	0.61M
December 31, 2019	0.52M
September 30, 2019	-0.041M
June 30, 2019	0.649M
March 31, 2019	-0.005M
December 31, 2018	0.771M
September 30, 2018	-0.007M
June 30, 2018	-1.118M
March 31, 2018	129.43M
December 31, 2017	106.60M
September 30, 2017	0.189M
June 30, 2017	0.579M
March 31, 2017	0.029M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-0.041M

Minimum

Sep 2019

328.87M

Maximum

Jun 2020

39.11M

Average

3.00M

Median

Sep 2022

Cash from Financing (Quarterly) Benchmarks

Gilead Sciences Inc	-1.099B
Catalyst Pharmaceuticals Inc	-0.665M
Integra Lifesciences Holdings Corp	-6.89M
Palatin Technologies Inc	4.974M
Petros Pharmaceuticals Inc	-2.373M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-88.00M
Cash from Investing (Quarterly)	28.00M
Free Cash Flow	-330.00M
Free Cash Flow Per Share (Quarterly)	-1.25
Free Cash Flow to Equity (Quarterly)	-94.00M
Free Cash Flow to Firm (Quarterly)	-94.00M
Free Cash Flow Yield	-28.67%